GLP-1
PulseAugur coverage of GLP-1 — every cluster mentioning GLP-1 across labs, papers, and developer communities, ranked by signal.
3 天有情绪数据
-
GLP-1 drugs may reduce cancer progression, new study suggests
New research presented at the American Society of Clinical Oncology meeting suggests that GLP-1 medications, commonly used for diabetes and weight loss, may also reduce the progression of certain cancers. A study analyz…
-
Hanyu Pharmaceutical secures 327M yuan peptide API sales deal
Hanyu Pharmaceutical has entered into a framework agreement for the sale of peptide APIs with a partner, aiming for a minimum sales value of 327 million yuan. This agreement, signed on May 18th, is intended to expand th…
-
Hong Kong scientists explore GLP-1 drugs for stroke recovery aid
Scientists at the Chinese University of Hong Kong are exploring the use of GLP-1 drugs, commonly known for weight loss and diabetes treatment, to aid stroke recovery. Their research suggests that administering these dru…
-
LLMs and normalizing flows tackle incomplete healthcare data for treatment effect estimation
Researchers have developed a novel two-stage pipeline, CausalFlow-T, designed to improve treatment effect estimation from incomplete longitudinal electronic health records. The first stage utilizes a DAG-constrained nor…
-
RFK Jr. pushes for peptide deregulation, potentially sparking a new wellness boom
Robert F. Kennedy Jr. is advocating for the relaxation of federal restrictions on peptides, potentially creating a significant market boom for telehealth companies, compounding pharmacies, and wellness clinics. Despite …
-
Browser automation platforms Simplex and Finic launch open-source tools
Simplex and Finic are two new platforms designed to automate browser-based tasks for developers. Simplex focuses on streamlining the prior authorization process for healthcare providers by integrating with existing clin…